 Jason Tregellas
Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 32 | 2019 | 501 | 9.020 |
Why?
| | Brain | 45 | 2023 | 2490 | 6.990 |
Why?
| | Brain Mapping | 37 | 2023 | 532 | 4.890 |
Why?
| | Magnetic Resonance Imaging | 60 | 2023 | 3174 | 4.690 |
Why?
| | Nerve Net | 17 | 2020 | 232 | 4.620 |
Why?
| | Nicotinic Agonists | 9 | 2019 | 110 | 3.490 |
Why?
| | Nicotine | 10 | 2017 | 276 | 3.240 |
Why?
| | Schizophrenic Psychology | 9 | 2019 | 113 | 2.860 |
Why?
| | Neural Pathways | 10 | 2020 | 277 | 2.520 |
Why?
| | Sensory Gating | 5 | 2015 | 42 | 2.400 |
Why?
| | Feeding Behavior | 9 | 2023 | 601 | 2.190 |
Why?
| | Cerebral Cortex | 14 | 2020 | 416 | 2.180 |
Why?
| | Obesity | 16 | 2020 | 2746 | 2.070 |
Why?
| | Energy Intake | 9 | 2019 | 447 | 2.040 |
Why?
| | Hippocampus | 12 | 2023 | 735 | 1.990 |
Why?
| | Image Processing, Computer-Assisted | 21 | 2019 | 709 | 1.930 |
Why?
| | Overweight | 6 | 2020 | 502 | 1.900 |
Why?
| | Hunger | 7 | 2023 | 46 | 1.880 |
Why?
| | Attention | 7 | 2016 | 408 | 1.710 |
Why?
| | Epilepsies, Partial | 2 | 2021 | 28 | 1.550 |
Why?
| | Auditory Perception | 5 | 2014 | 106 | 1.500 |
Why?
| | Drug Resistant Epilepsy | 2 | 2021 | 48 | 1.490 |
Why?
| | Cues | 7 | 2022 | 297 | 1.450 |
Why?
| | Connectome | 3 | 2020 | 63 | 1.400 |
Why?
| | Food | 5 | 2022 | 162 | 1.370 |
Why?
| | Evoked Potentials, Auditory | 6 | 2015 | 201 | 1.330 |
Why?
| | Adult | 66 | 2022 | 31512 | 1.240 |
Why?
| | Acoustic Stimulation | 9 | 2016 | 321 | 1.220 |
Why?
| | Visual Perception | 7 | 2013 | 141 | 1.220 |
Why?
| | Appetite Regulation | 5 | 2019 | 26 | 1.210 |
Why?
| | Appetite | 9 | 2023 | 57 | 1.200 |
Why?
| | Epilepsy | 2 | 2021 | 290 | 1.140 |
Why?
| | Psychomotor Performance | 6 | 2016 | 290 | 1.110 |
Why?
| | Cognition | 4 | 2019 | 1024 | 1.100 |
Why?
| | Cognitive Dysfunction | 3 | 2023 | 301 | 1.100 |
Why?
| | Sex Characteristics | 4 | 2023 | 671 | 1.090 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2015 | 366 | 1.080 |
Why?
| | Executive Function | 3 | 2019 | 391 | 1.080 |
Why?
| | Male | 70 | 2023 | 57801 | 1.030 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 5 | 2019 | 105 | 1.010 |
Why?
| | Neurons | 6 | 2017 | 1345 | 0.980 |
Why?
| | Female | 69 | 2023 | 61564 | 0.940 |
Why?
| | Prefrontal Cortex | 6 | 2013 | 275 | 0.940 |
Why?
| | Humans | 90 | 2023 | 118972 | 0.920 |
Why?
| | Neuroimaging | 3 | 2020 | 256 | 0.910 |
Why?
| | Reward | 6 | 2019 | 209 | 0.900 |
Why?
| | Antipsychotic Agents | 3 | 2014 | 193 | 0.900 |
Why?
| | Benzylidene Compounds | 3 | 2016 | 25 | 0.880 |
Why?
| | Single-Blind Method | 8 | 2017 | 269 | 0.860 |
Why?
| | Cerebellum | 3 | 2013 | 203 | 0.840 |
Why?
| | Headache | 1 | 2023 | 128 | 0.840 |
Why?
| | Cross-Over Studies | 9 | 2016 | 456 | 0.820 |
Why?
| | Eating | 4 | 2023 | 369 | 0.810 |
Why?
| | Pursuit, Smooth | 4 | 2010 | 23 | 0.770 |
Why?
| | Receptors, Nicotinic | 3 | 2013 | 295 | 0.760 |
Why?
| | Satiation | 4 | 2019 | 24 | 0.760 |
Why?
| | Electrocorticography | 1 | 2020 | 14 | 0.750 |
Why?
| | Noise | 2 | 2012 | 67 | 0.750 |
Why?
| | Sensation Disorders | 2 | 2013 | 33 | 0.740 |
Why?
| | Cholinergic Agents | 3 | 2016 | 18 | 0.740 |
Why?
| | Neurovascular Coupling | 1 | 2019 | 7 | 0.730 |
Why?
| | Torticollis | 1 | 2019 | 12 | 0.720 |
Why?
| | Magnetoencephalography | 1 | 2020 | 103 | 0.720 |
Why?
| | Exercise | 4 | 2017 | 1657 | 0.700 |
Why?
| | Pyridines | 3 | 2016 | 440 | 0.680 |
Why?
| | Cognition Disorders | 5 | 2019 | 529 | 0.670 |
Why?
| | Oxygen | 10 | 2017 | 854 | 0.670 |
Why?
| | Neuronal Plasticity | 1 | 2020 | 219 | 0.660 |
Why?
| | Middle Aged | 32 | 2019 | 27617 | 0.660 |
Why?
| | Food Preferences | 2 | 2016 | 119 | 0.620 |
Why?
| | Reaction Time | 7 | 2015 | 392 | 0.610 |
Why?
| | Thalamus | 2 | 2009 | 80 | 0.600 |
Why?
| | Hemodynamics | 2 | 2019 | 1003 | 0.600 |
Why?
| | Parkinson Disease | 2 | 2023 | 334 | 0.590 |
Why?
| | Memory, Short-Term | 1 | 2019 | 233 | 0.580 |
Why?
| | Antiparkinson Agents | 1 | 2016 | 26 | 0.580 |
Why?
| | Electroencephalography | 5 | 2021 | 387 | 0.550 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 356 | 0.550 |
Why?
| | Analysis of Variance | 7 | 2017 | 1293 | 0.540 |
Why?
| | Diet, Ketogenic | 1 | 2015 | 32 | 0.540 |
Why?
| | Repetition Priming | 1 | 2015 | 8 | 0.530 |
Why?
| | Motor Activity | 2 | 2019 | 660 | 0.530 |
Why?
| | Nutrition Policy | 1 | 2015 | 58 | 0.510 |
Why?
| | Limbic System | 2 | 2015 | 42 | 0.510 |
Why?
| | Neuropsychological Tests | 10 | 2023 | 1032 | 0.500 |
Why?
| | Clozapine | 1 | 2014 | 21 | 0.490 |
Why?
| | Leptin | 2 | 2012 | 231 | 0.480 |
Why?
| | Endophenotypes | 1 | 2013 | 28 | 0.470 |
Why?
| | Psychotropic Drugs | 1 | 2014 | 58 | 0.470 |
Why?
| | Body Mass Index | 6 | 2023 | 2092 | 0.460 |
Why?
| | Brain Waves | 1 | 2013 | 22 | 0.460 |
Why?
| | Fingers | 1 | 2013 | 83 | 0.460 |
Why?
| | Semantics | 2 | 2013 | 97 | 0.450 |
Why?
| | Behavior Therapy | 1 | 2015 | 237 | 0.450 |
Why?
| | Dronabinol | 1 | 2014 | 121 | 0.440 |
Why?
| | Frontal Lobe | 4 | 2016 | 148 | 0.440 |
Why?
| | Efficiency | 1 | 2012 | 89 | 0.410 |
Why?
| | Psychiatric Status Rating Scales | 4 | 2017 | 499 | 0.400 |
Why?
| | Patient Compliance | 1 | 2015 | 537 | 0.400 |
Why?
| | Bipolar Disorder | 2 | 2010 | 209 | 0.390 |
Why?
| | Autistic Disorder | 3 | 2009 | 168 | 0.380 |
Why?
| | Hallucinations | 1 | 2010 | 29 | 0.380 |
Why?
| | Space Perception | 1 | 2010 | 65 | 0.360 |
Why?
| | Thinking | 2 | 2009 | 54 | 0.360 |
Why?
| | Functional Neuroimaging | 4 | 2019 | 67 | 0.350 |
Why?
| | Functional Laterality | 4 | 2013 | 208 | 0.350 |
Why?
| | Photic Stimulation | 6 | 2016 | 204 | 0.350 |
Why?
| | Urbanization | 1 | 2009 | 25 | 0.340 |
Why?
| | Statistics as Topic | 4 | 2017 | 307 | 0.340 |
Why?
| | Nutritional Status | 1 | 2011 | 300 | 0.330 |
Why?
| | Reproducibility of Results | 4 | 2023 | 2874 | 0.330 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2015 | 1945 | 0.320 |
Why?
| | Body Weight | 1 | 2012 | 934 | 0.320 |
Why?
| | Anorexia Nervosa | 3 | 2014 | 74 | 0.310 |
Why?
| | Case-Control Studies | 7 | 2017 | 3171 | 0.300 |
Why?
| | Young Adult | 14 | 2020 | 10793 | 0.300 |
Why?
| | Hyperphagia | 3 | 2019 | 32 | 0.300 |
Why?
| | Child | 9 | 2021 | 19129 | 0.290 |
Why?
| | Decision Making | 1 | 2013 | 809 | 0.280 |
Why?
| | Taste | 3 | 2014 | 218 | 0.260 |
Why?
| | Computer Graphics | 2 | 2015 | 48 | 0.250 |
Why?
| | Social Behavior | 1 | 2006 | 276 | 0.240 |
Why?
| | Ocular Motility Disorders | 1 | 2004 | 27 | 0.240 |
Why?
| | Animals | 9 | 2019 | 33381 | 0.230 |
Why?
| | Child Development Disorders, Pervasive | 2 | 2013 | 61 | 0.210 |
Why?
| | Biomarkers | 4 | 2019 | 3588 | 0.210 |
Why?
| | Atrophy | 3 | 2023 | 164 | 0.210 |
Why?
| | Learning | 1 | 2006 | 374 | 0.210 |
Why?
| | Gyrus Cinguli | 3 | 2007 | 68 | 0.210 |
Why?
| | Weight Loss | 2 | 2019 | 655 | 0.190 |
Why?
| | Maternal Inheritance | 1 | 2020 | 15 | 0.190 |
Why?
| | Fasting | 4 | 2019 | 264 | 0.190 |
Why?
| | Smoking | 2 | 2007 | 1487 | 0.190 |
Why?
| | Organ Size | 3 | 2012 | 460 | 0.190 |
Why?
| | Rest | 1 | 2020 | 104 | 0.180 |
Why?
| | Neural Inhibition | 2 | 2015 | 160 | 0.180 |
Why?
| | Parietal Lobe | 2 | 2013 | 42 | 0.180 |
Why?
| | Substance-Related Disorders | 3 | 2013 | 971 | 0.170 |
Why?
| | Thinness | 2 | 2011 | 91 | 0.170 |
Why?
| | Transcranial Magnetic Stimulation | 1 | 2019 | 43 | 0.170 |
Why?
| | Diet, Reducing | 1 | 2019 | 81 | 0.170 |
Why?
| | Seizures | 1 | 2021 | 345 | 0.170 |
Why?
| | Energy Metabolism | 2 | 2014 | 767 | 0.160 |
Why?
| | Drug Users | 2 | 2016 | 39 | 0.160 |
Why?
| | Longitudinal Studies | 2 | 2023 | 2513 | 0.160 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 229 | 0.160 |
Why?
| | Surveys and Questionnaires | 5 | 2017 | 4708 | 0.160 |
Why?
| | Food Analysis | 1 | 2017 | 18 | 0.160 |
Why?
| | Mice | 4 | 2015 | 15520 | 0.160 |
Why?
| | Temporal Lobe | 2 | 2020 | 90 | 0.150 |
Why?
| | Gastric Bypass | 1 | 2019 | 93 | 0.150 |
Why?
| | Child, Preschool | 3 | 2020 | 9491 | 0.150 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2019 | 157 | 0.150 |
Why?
| | Tobacco Use Disorder | 1 | 2019 | 233 | 0.150 |
Why?
| | Levodopa | 1 | 2016 | 23 | 0.140 |
Why?
| | Adolescent | 8 | 2020 | 18480 | 0.140 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 7 | 0.140 |
Why?
| | Social Control, Informal | 2 | 2013 | 19 | 0.140 |
Why?
| | Cerebrovascular Circulation | 2 | 2009 | 204 | 0.140 |
Why?
| | Basal Metabolism | 1 | 2016 | 50 | 0.140 |
Why?
| | Aversive Therapy | 1 | 2015 | 3 | 0.140 |
Why?
| | Dietary Fiber | 1 | 2016 | 44 | 0.130 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 323 | 0.130 |
Why?
| | Lost to Follow-Up | 1 | 2015 | 21 | 0.130 |
Why?
| | Ketones | 1 | 2015 | 45 | 0.130 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1795 | 0.130 |
Why?
| | Hormones | 1 | 2016 | 135 | 0.130 |
Why?
| | Cohort Studies | 3 | 2020 | 5116 | 0.130 |
Why?
| | Choice Behavior | 1 | 2016 | 160 | 0.130 |
Why?
| | Treatment Outcome | 2 | 2021 | 9342 | 0.130 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 247 | 0.130 |
Why?
| | Dietary Proteins | 1 | 2016 | 130 | 0.130 |
Why?
| | Administration, Cutaneous | 1 | 2014 | 119 | 0.130 |
Why?
| | Psychotic Disorders | 2 | 2007 | 135 | 0.120 |
Why?
| | Time Factors | 3 | 2015 | 6412 | 0.120 |
Why?
| | Sweetening Agents | 1 | 2014 | 52 | 0.120 |
Why?
| | CA3 Region, Hippocampal | 1 | 2014 | 6 | 0.120 |
Why?
| | Signal-To-Noise Ratio | 1 | 2014 | 59 | 0.120 |
Why?
| | Gamma Rhythm | 1 | 2013 | 5 | 0.120 |
Why?
| | Computer Simulation | 2 | 2019 | 922 | 0.120 |
Why?
| | Mice, Inbred DBA | 1 | 2014 | 174 | 0.120 |
Why?
| | Psycholinguistics | 1 | 2013 | 17 | 0.110 |
Why?
| | Regression Analysis | 4 | 2019 | 983 | 0.110 |
Why?
| | Mice, Inbred C3H | 1 | 2013 | 250 | 0.110 |
Why?
| | Symptom Assessment | 1 | 2014 | 123 | 0.110 |
Why?
| | Blood Glucose | 2 | 2019 | 1939 | 0.110 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 283 | 0.110 |
Why?
| | Heart Rate | 1 | 2017 | 729 | 0.110 |
Why?
| | Satiety Response | 1 | 2012 | 8 | 0.110 |
Why?
| | Drug Discovery | 1 | 2013 | 124 | 0.110 |
Why?
| | Weight Gain | 2 | 2013 | 493 | 0.110 |
Why?
| | Aged | 3 | 2019 | 19657 | 0.110 |
Why?
| | Drug Interactions | 1 | 2014 | 352 | 0.110 |
Why?
| | Insulin | 2 | 2019 | 2162 | 0.110 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4552 | 0.110 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 164 | 0.100 |
Why?
| | Models, Animal | 1 | 2014 | 363 | 0.100 |
Why?
| | Body Composition | 1 | 2016 | 653 | 0.100 |
Why?
| | Fornix, Brain | 1 | 2011 | 6 | 0.100 |
Why?
| | Conduct Disorder | 1 | 2013 | 191 | 0.100 |
Why?
| | Parents | 2 | 2012 | 1212 | 0.100 |
Why?
| | Marijuana Abuse | 1 | 2014 | 209 | 0.100 |
Why?
| | Sensation | 1 | 2011 | 43 | 0.100 |
Why?
| | Health Behavior | 1 | 2017 | 720 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2017 | 468 | 0.100 |
Why?
| | Subliminal Stimulation | 1 | 2010 | 2 | 0.100 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2011 | 46 | 0.100 |
Why?
| | Pregnancy | 2 | 2020 | 5690 | 0.100 |
Why?
| | Algorithms | 2 | 2019 | 1541 | 0.100 |
Why?
| | Exercise Test | 1 | 2013 | 551 | 0.100 |
Why?
| | Speech Perception | 1 | 2012 | 81 | 0.100 |
Why?
| | Eye Movements | 1 | 2010 | 56 | 0.090 |
Why?
| | Facial Expression | 1 | 2010 | 62 | 0.090 |
Why?
| | Models, Statistical | 1 | 2014 | 636 | 0.090 |
Why?
| | Blood Pressure | 1 | 2017 | 1664 | 0.090 |
Why?
| | Outpatients | 1 | 2012 | 325 | 0.090 |
Why?
| | Self-Injurious Behavior | 1 | 2011 | 120 | 0.090 |
Why?
| | Colorado | 2 | 2019 | 4196 | 0.090 |
Why?
| | Diet | 2 | 2017 | 1153 | 0.090 |
Why?
| | Corpus Striatum | 1 | 2010 | 127 | 0.090 |
Why?
| | Fragile X Syndrome | 1 | 2009 | 80 | 0.080 |
Why?
| | Artifacts | 2 | 2007 | 125 | 0.080 |
Why?
| | Family | 1 | 2012 | 585 | 0.080 |
Why?
| | Reference Values | 2 | 2008 | 774 | 0.080 |
Why?
| | Arousal | 1 | 2009 | 157 | 0.080 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2025 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2009 | 1687 | 0.080 |
Why?
| | Dominance, Cerebral | 1 | 2007 | 53 | 0.080 |
Why?
| | Genotype | 2 | 2010 | 1882 | 0.080 |
Why?
| | Visual Fields | 2 | 2005 | 78 | 0.080 |
Why?
| | Aggression | 1 | 2009 | 183 | 0.080 |
Why?
| | Nerve Fibers | 1 | 2007 | 89 | 0.070 |
Why?
| | Auditory Cortex | 1 | 2007 | 41 | 0.070 |
Why?
| | Stereotyped Behavior | 1 | 2006 | 21 | 0.070 |
Why?
| | Postprandial Period | 2 | 2019 | 96 | 0.070 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 239 | 0.070 |
Why?
| | Prospective Studies | 2 | 2017 | 6471 | 0.070 |
Why?
| | Hypothalamus | 1 | 2007 | 155 | 0.070 |
Why?
| | Communication Disorders | 1 | 2006 | 16 | 0.070 |
Why?
| | Rats | 1 | 2015 | 5392 | 0.070 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 10 | 0.070 |
Why?
| | Intelligence | 1 | 2006 | 136 | 0.070 |
Why?
| | Judgment | 1 | 2006 | 59 | 0.070 |
Why?
| | Emotions | 1 | 2010 | 495 | 0.070 |
Why?
| | Visual Cortex | 1 | 2005 | 40 | 0.070 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3730 | 0.070 |
Why?
| | Visual Pathways | 1 | 2005 | 43 | 0.060 |
Why?
| | Amygdala | 2 | 2016 | 175 | 0.060 |
Why?
| | Breakfast | 2 | 2016 | 17 | 0.060 |
Why?
| | Pain | 1 | 2010 | 735 | 0.060 |
Why?
| | Area Under Curve | 1 | 2005 | 296 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2007 | 749 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2020 | 12978 | 0.060 |
Why?
| | Head | 1 | 2004 | 89 | 0.060 |
Why?
| | Risk Factors | 2 | 2017 | 9000 | 0.060 |
Why?
| | Basal Ganglia | 1 | 2023 | 44 | 0.060 |
Why?
| | Promoter Regions, Genetic | 1 | 2007 | 1158 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2010 | 2062 | 0.050 |
Why?
| | Movement | 1 | 2004 | 248 | 0.050 |
Why?
| | Insulin Resistance | 2 | 2019 | 1180 | 0.050 |
Why?
| | Interview, Psychological | 2 | 2013 | 93 | 0.050 |
Why?
| | Peptide YY | 1 | 2019 | 10 | 0.040 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2012 | 220 | 0.040 |
Why?
| | Ghrelin | 1 | 2019 | 30 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2019 | 103 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 403 | 0.040 |
Why?
| | Models, Neurological | 1 | 2019 | 216 | 0.040 |
Why?
| | Language | 1 | 2019 | 271 | 0.040 |
Why?
| | Lunch | 1 | 2016 | 7 | 0.030 |
Why?
| | Machine Learning | 1 | 2019 | 331 | 0.030 |
Why?
| | Homeostasis | 1 | 2019 | 594 | 0.030 |
Why?
| | Taste Perception | 1 | 2014 | 28 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 140 | 0.030 |
Why?
| | Pleasure | 1 | 2013 | 18 | 0.030 |
Why?
| | Mothers | 1 | 2019 | 682 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1129 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2013 | 180 | 0.030 |
Why?
| | Sucrose | 1 | 2012 | 104 | 0.030 |
Why?
| | Conditioning, Operant | 1 | 2012 | 103 | 0.030 |
Why?
| | Anisotropy | 1 | 2011 | 65 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3003 | 0.020 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2011 | 90 | 0.020 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2008 | 9 | 0.020 |
Why?
| | Temperance | 1 | 2008 | 15 | 0.020 |
Why?
| | Amphetamine-Related Disorders | 1 | 2008 | 28 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4596 | 0.020 |
Why?
| | Lod Score | 1 | 2007 | 75 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2008 | 107 | 0.020 |
Why?
| | Alcohol-Related Disorders | 1 | 2008 | 111 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1868 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2008 | 499 | 0.020 |
Why?
| | Chewing Gum | 1 | 2004 | 8 | 0.020 |
Why?
| | Verbal Behavior | 1 | 2004 | 48 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2005 | 321 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 642 | 0.010 |
Why?
| | Genetic Markers | 1 | 2005 | 348 | 0.010 |
Why?
| | Early Diagnosis | 1 | 2005 | 230 | 0.010 |
Why?
| | Gene Frequency | 1 | 2005 | 513 | 0.010 |
Why?
| | Administration, Oral | 1 | 2005 | 756 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2275 | 0.010 |
Why?
| | Fourier Analysis | 1 | 2002 | 41 | 0.010 |
Why?
|
|
Tregellas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|